TERAIMMUNE
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis, and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
TERAIMMUNE
Industry:
Biotechnology Genetics Health Care Life Science
Founded:
2016-09-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.teraimmune.com
Total Employee:
11+
Status:
Active
Contact:
301-232-4105
Total Funding:
2.96 M USD
Technology used in webpage:
Domain Not Resolving Euro
Similar Organizations
Apton Biosystems
Apton Biosystems develops an optical system designed for sequencing and protein detection.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Color
Color is a complete platform for healthcare delivery.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Nkarta Therapeutics
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Jay Park Co-Founder and Chief Operating Officer @ TeraImmune
Co-Founder and Chief Operating Officer
2019-09-01
Yong Chan Kim Founder and Chief Executive Officer @ TeraImmune
Founder and Chief Executive Officer
2019-08-01
Dennis Hahm Business Development Director @ TeraImmune
Business Development Director
2020-12-01
Founder
Investors List
Shinhan Venture Investment
Shinhan Venture Investment investment in Venture Round - TeraImmune
More informations about "TeraImmune"
TeraImmune - Crunchbase Company Profile & Funding
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg …See details»
TeraImmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore TeraImmune, Inc. with its drug pipeline, therapeutic area, technology platform, 10 news, and 1 literature, Disease Domain:Nervous System Diseases, Hemic and Lymphatic Diseases, …See details»
TeraImmune - Products, Competitors, Financials, Employees, …
About TeraImmune. TeraImmune develops cell therapeutics for autoimmune diseases and immune-related disorders. It uses regulatory T (Treg) cells from a donor and makes cells for …See details»
Teraimmune LLC | www.inknowvation.com
Jul 17, 2023 TeraImmune, Inc is a pre-clinical stage immune cell therapeutics company structured around development of the regulatory T cell (Treg) therapy in hemophilia A (HA) …See details»
TeraImmune - Funding, Financials, Valuation & Investors
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. New. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
TeraImmune - VentureRadar
TeraImmune, Inc. is a biotechnology company that develops innovative immune-cell therapies. Our investigational technology programs regulatory T (Treg) cells to recognize and suppress …See details»
TeraImmune - Ownership and Business Overview - Mergr
TeraImmune is privately held a biotechnology company focused on the discovery and development of novel Treg-based cell therapies for autoimmune diseases. The company's …See details»
Baudax Bio Acquires TeraImmune, Inc. - GlobeNewswire
Jun 30, 2023 TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax Baudax Bio …See details»
Tera Immune - Company Info, Employees & Competitors
View Teraimmune teraimmune.com location in 704 quince orch rd, gaithersburg, maryland, 20878, united states, revenue, industry and description. Find related and similar companies as …See details»
Teraimmune 2025 Company Profile: Valuation, …
Teraimmune General Information Description. Developer of cell therapeutics designed to treat autoimmune diseases and immune-related disorders. The company uses regulatory Treg cells from a donor to create Treg cells for …See details»
TeraImmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax Baudax Bio CEO Gerri …See details»
Baudax Bio acquires biotechnology firm TeraImmune
Jul 3, 2023 The merged business will expedite TeraImmune’s immune cell therapy development by utilising a dual Treg production platform comprising both natural Tregs and induced Tregs. …See details»
TeraImmune Company Profile: Overview and Full News Analysis
News Summary Baudax Bio has acquired all the outstanding equity interests of TeraImmune in a stock-for-stock deal . The combined entity will also develop a FVIII-specific Treg therapy …See details»
TeraImmune - Contacts, Employees, Board Members, Advisors
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. New. Resources. ... Experience the new Crunchbase, powered by AI . …See details»
TeraImmune, Inc. (TeraImmune, Inc.) - 药物管线_专利_临床试验_投 …
了解TeraImmune, Inc. (TeraImmune, Inc.)公司的药物管线，治疗领域，技术平台，以及它的7篇新闻和1篇文献，疾病领域:神经系统疾病，血液及淋巴系统疾病，免疫系统疾病，技术平台:TCR …See details»
TeraImmune Receives FDA IND Clearance to Initiate Phase 1/2a …
Oct 11, 2022 TeraImmune Receives FDA IND Clearance to Initiate Phase 1/2a Clinical Trial of TI-168 for Treatment of Hemophilia A with Refractory Inhibitors TeraImmune, Inc. Tue, Oct 11, …See details»
Baudax Bio Acquires TeraImmune, Inc. - Yahoo Finance
Jun 30, 2023 TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax Baudax Bio …See details»
TeraImmune Team-up That Will Aid MS Treg Therapies Extended
Jan 6, 2023 TeraImmune is a biotechnology company working to develop new Treg-based therapies, made by equipping natural or lab-made Tregs with a disease-specific receptor that …See details»
TeraImmune Extends CRADA for Development of Treg Expansion
Jan 4, 2023 TeraImmune has received FDA IND clearance to initiate a Phase 1/2a clinical trial of TI-168 for the treatment of congenital Hemophilia A with refractory inhibitors. Its Treg platform …See details»
TeraImmune Receives FDA IND Clearance to Initiate Phase
Oct 11, 2022 TeraImmune, Inc. is a biotechnology company that develops innovative immune-cell therapies. The Company is leveraging a dual Treg manufacturing platform consisting of …See details»